Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2015 Feb 1;8(2):2039–2043.

MC4R expression in pedunculopontine nucleus involved in the modulation of midbrain dopamine system

Yan Hao 1, Xue-Bi Tian 2, Tao-Tao Liu 2, Cheng Liu 2, Hong-Bing Xiang 2, Jian-Guo Zhang 3,4,5
PMCID: PMC4396322  PMID: 25973101

Abstract

Background and objective: Separate studies have implicated the pedunculopontine tegmental nucleus (PPTg) in processing aversive stimuli to dopamine systems, and melanocortin-4 receptor (MC4R) are broadly expressed by the neurons in the PPTg, but the exact neurosubstrate underlying the regulation of dopamine systems by the central melanocortin pathway is poorly understood. Methods: In this study, the PPTg of 6 adult mice expressing green fluorescent protein (GFP) under the control of the MC4R promoter was detected by fluorescence immunohistochemistry. Results: A large number of GFP-positive neurons in the dissipated parts of PPTg (dpPPTg) were found, and approximately 50% of MC4R-GFP- positive neurons in the dpPPTg coexpressed tyrosine hydroxylase, a marker of dopamine neurons, indicating that they were dopaminergic. Conclusions: Our findings support the hypothesis that MC4R signaling in the dpPPTg may involve in the modulation of midbrain dopamine systems.

Keywords: Melanocortin-4 receptor, dopamine, the pedunculopontine tegmental nucleus

Introduction

It is well known that midbrain dopamine neurons play an important role in Parkinson’s disease [1]. The pedunculopontine tegmental nucleus (PPTg), a part of the mesencephalic locomotor region, is involved in the gait disturbance that characterized parkinsonian syndromes [2,3]. Neurons in the PPTg exhibit the sophisticated neurochemical properties, including cholinergic, serotonergic, catecholaminergic, GABAergic and glutamatergic-containing neurons [4-9]. Previous studies in rat and mouse documented that a subpopulation of PPTg neurons expresses the melanocortin-4 receptor (MC4R), a G protein-coupled, seven-transmembrane receptor expressed in the brain [10-13]. Otherwise, there is evidence that the melanocortins can act on mesolimbic dopamine pathways [14]. These data suggest that there exist a tight link between MC4R and dopaminergic system in the PPTg. We speculate that MC4R in the PPTg may primarily involve in the modulation of midbrain dopamine systems.

Although it is now widely recognized that dopaminergic activity are tightly interconnected via central melanocortinergic pathways involving the MC4R [15-17], the exact neurosubstrate underlying the regulation of dopamine systems by the central melanocortin circuit is poorly understood. Many studies have shown that tyrosine hydroxylase (TH) is the marker of midbrain dopamine neurons [1,18-21]. The main objective of this study is to provide direct neuroanatomical evidence for the central melanocortin-dopaminergic circuits in the PPTg using fluorescence immunohistochemical detection.

Materials and methods

Animal care

Generation of MC4R-GFP mice was described previously [22,23]. Male mice between 7 and 12 weeks old were used for the experiments. All the mice were housed under a 12 h light/dark cycle with food and water provided ad libitum. All experiments were performed in accordance with the guidelines of the NIH and the International Association for the Study of Pain and were approved by the Institutional Animal Care and Use Committees at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology University.

Immunohistochemistry

Standard procedures were used as described previously [22,24]. Briefly, mice were anesthetized with the mixture of ketamine (10 mg/ml) and xylazine (0.5 mg/ml) by intraperitoneal injection, and fixed by intracardiac perfusion of cold 0.01 M PBS (pH 7.4) and 4% paraformaldehyde. Brain tissues were immediately removed, post-fixed in the same fixative overnight at 4°C, and cryoprotected in 30% sucrose PBS solution.

Brain tissues were frozen and sectioned at 25 μm thickness on a cryostat. Free-floating sections were blocked in a solution containing 2% donkey serum and 0.3% Triton X-100 in PBS for 1 h at room temperature. The sections were incubated with primary antibodies overnight at 4°C followed by secondary antibodies. The following primary antibodies were used at the specified dilutions: a chicken polyclonal antibody against GFP (ab13970, 1:1,000; Abcam), rabbit anti-TH (1:2000; Chemicon International, Temecula, CA). The secondary antibodies included Cy3- or FITC-conjugated donkey anti-rabbit or anti-mouse IgG (1:1,000, Invitrogen, Molecular Probes, Eugene, OR). Finally, the sections were washed in 0.1 M PBS, mounted on gelatin-coated slides, dried, and observed via the fluorescence microscope (Leica DM2500) .When taking pictures, we defined the FITC as the red while the Cy3 as the green.

Results

Specific expression of TH and MC4R-GFP in the PPTg

TH-positive neurons were observed in the dissipated parts of PPTg (dpPPTg) but TH-positive fibers expressed in the compact parts of PPTg (cpPPTg) (Figure 1A1-A3). We assayed GFP expression in the MC4R-GFP reporter mouse and observed a large number of GFP-positive neurons in the dpPPTg (Figure 1C) and the cpPPTg.

Figure 1.

Figure 1

Colocalization of TH in subsets of MC4R-GFP positive neurons within PPTg areas. (A1-A3 and B) show TH- positive neurons (green); (A2) indicates split channel image of the corresponding PPTg area in panel (A1) during high magnification. (C) shows MC4R-GFP -positive neuron (red); (D) shows overlaid images of (B) plus (C). Arrows indicate double-labeled neurons (yellow). TH and MC4R-GFP are broadly expressed by the neurons in the dpPPTg. In contrast to the dpPPTg, we did not detect dual labeled neurons in the compact (cp) parts of PPTg (cpPPTg). Aq, aqueduct; DR, doral raphe; dpPPTg, the dissipated parts of the PPTg; cpPPTg, the compact parts of the PPTg. Some drawings were taken from HB Xiang (Brain 2013, Med Hypotheses 2011, Epilepsy & Behavior 2013). Scale bar: 400 μm for (A1), 200 μm for (A2 and A3), 100 μm for (B-D).

MC4R-GFP and TH co-expression in the PPTg

We found that double-labeled MC4R-GFP/TH neurons were mainly located in the dpPPTg, and approximately 50% of MC4R-GFP-positive neurons coexpressed TH-immunoreactive cells in the dpPPTg (Figure 1D). In contrast to the dpPPTg, we did not detect dual labeled neurons in the cpPPTg.

Discussion

In this study, we used a unique MC4R-green-fluorescent protein transgenic mouse model to demonstrate the distribution of MC4R-GFP and TH in the caudal parts of PPTg. Three major findings have emerged from this investigation: 1) a large number of GFP-positive neurons were located in the dpPPTg and cpPPTg; 2) approximately 50% of the MC4R-GFP-positive neurons were TH-immunoreactive cells in the dpPPTg; and 3) MC4R-GFP-positive neurons in the cpPPTg were not coexpressed with TH.

Some research has identified that the MC4R interacts with dopaminergic systems involved in the regulation of physiological and behavioral processes [25,26]. Lindblom et al reported that alpha- melanocyte stimulating hormone (alpha-MSH) administered into the ventral tegmental area induced a significant increase in dopamine and DOPAC levels in the nucleus accumbens, and this increase was completely blocked by pre-treatment with the MC4R selective antagonist HS131, indicating that the MC4R may mediate the effects of alpha-MSH on dopamine transmission [25]. Lute et al reported that the hypometabolic/hypothermic effect of the nonselective melanocortin agonist MTII was prevented by dopamine antagonists, and MTII selectively activated arcuate nucleus dopaminergic neurons [27]. Cuit et al reported that the development of locomotor sensitization to repeated administration of cocaine was blunted in MC4R-null mice and normalized in MC4R/dopamine 1 receptor (D1R) mice, suggesting that the effects of MC4R signaling within D1R neurons may be involved in the long-term regulation of energy balance and behavioral responses to cocaine [28]. These data highlight that the MC4R contributes to a regulated response occurring at dopaminergic neurons, potentially beneficial during extreme physiologic stress. We found that approximately 50% of the MC4R-GFP-positive neurons were TH-immunoreactive cells in the caudal parts of PPTg, this result was consistent with the concept that melanocortins may act on mesolimbic dopamine pathways [14], indicating that MC4R expression in the PPTg is hypothesized to be involved in the modulation of midbrain dopamine systems.

Early studies of PPTg neurons contained at least six neuronal phenotypes: dopaminergic, cholinergic, serotonergic, catecholaminergic, glutamatergic, and GABAergic cells, but our work had emphasized its MC4R-positive neurons. It has been established that the PPTg areas are crucial for motor processes and behavioral state control [29]. There is growing evidence that the participation of midbrain melanocortinergic systems in diverse clinical contexts suggests these systems are highly complex, including energy balance, glucose homeostasis, and nociception [12,14,22,30-32]. It has been shown previously that there is a physiological role of MC4R-mediated signaling, for example, MC4R enhances adenylyl cyclase activity by coupling to the stimulatory G protein (Gs), and leads to increased cyclic AMP (cAMP) production that subsequently increases the activity of protein kinase A (PKA) [33-35]. The present results showed that MC4R-positive neurons within midbrain dopamine regions may play important roles in motor processes and behavioral state control.

In summary, the results of the present study demonstrated that double-labeled MC4R-GFP/TH neurons were mainly located in the dpPPTg, suggesting that melanocortin-4 receptor expression in the PPTg may be involved in the modulation of midbrain dopamine systems. Further work on elucidating the organization, function and modification of midbrain melanocortin-dopaminergic circuits will importantly contribute to understanding the importance of central melanocortinergic system in mediating the pathophysiology of midbrain motivational systems.

Acknowledgements

We gratefully acknowledge Dr. Joel Elmquist for providing MC4R-GFP transgenic mice. This work was supported by grants from National Natural Science Foundation of China (No. 81171217 to J.Z.), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (No. ZY-201305 to J.Z.).

Disclosure of conflict of interest

None.

References

  • 1.Luquin MR, Montoro RJ, Guillen J, Saldise L, Insausti R, Del Rio J, Lopez-Barneo J. Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron. 1999;22:743–750. doi: 10.1016/s0896-6273(00)80733-3. [DOI] [PubMed] [Google Scholar]
  • 2.Insola A, Padua L, Scarnati E, Valeriani M. Where are the somatosensory evoked potentials recorded from DBS leads implanted in the human pedunculopontine tegmental nucleus generated? Mov Disord. 2011;26:1573–1574. doi: 10.1002/mds.23589. [DOI] [PubMed] [Google Scholar]
  • 3.Winn P. Experimental studies of pedunculopontine functions: are they motor, sensory or integrative? Parkinsonism Relat Disord. 2008;14(Suppl 2):S194–198. doi: 10.1016/j.parkreldis.2008.04.030. [DOI] [PubMed] [Google Scholar]
  • 4.Leonard CS, Kerman I, Blaha G, Taveras E, Taylor B. Interdigitation of nitric oxide synthase-, tyrosine hydroxylase-, and serotonin-containing neurons in and around the laterodorsal and pedunculopontine tegmental nuclei of the guinea pig. J Comp Neurol. 1995;362:411–432. doi: 10.1002/cne.903620309. [DOI] [PubMed] [Google Scholar]
  • 5.Wang HL, Morales M. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur J Neurosci. 2009;29:340–358. doi: 10.1111/j.1460-9568.2008.06576.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Motts SD, Schofield BR. Cholinergic and non-cholinergic projections from the pedunculopontine and laterodorsal tegmental nuclei to the medial geniculate body in Guinea pigs. Front Neuroanat. 2010;4:137. doi: 10.3389/fnana.2010.00137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Martinez-Gonzalez C, Bolam JP, Mena-Segovia J. Topographical organization of the pedunculopontine nucleus. Front Neuroanat. 2011;5:22. doi: 10.3389/fnana.2011.00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Holmstrand EC, Sesack SR. Projections from the rat pedunculopontine and laterodorsal tegmental nuclei to the anterior thalamus and ventral tegmental area arise from largely separate populations of neurons. Brain Struct Funct. 2011;216:331–45. doi: 10.1007/s00429-011-0320-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Garcia-Rill E, Skinner RD. The mesencephalic locomotor region. I. Activation of a medullary projection site. Brain Res. 1987;411:1–12. doi: 10.1016/0006-8993(87)90675-5. [DOI] [PubMed] [Google Scholar]
  • 10.Dores RM, Londraville RL, Prokop J, Davis P, Dewey N, Lesinski N. Molecular evolution of GPCRs: Melanocortin/melanocortin receptors. J Mol Endocrinol. 2014;52:T29–T42. doi: 10.1530/JME-14-0050. [DOI] [PubMed] [Google Scholar]
  • 11.Liu H, Kishi T, Roseberry AG, Cai X, Lee CE, Montez JM, Friedman JM, Elmquist JK. Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter. J Neurosci. 2003;23:7143–7154. doi: 10.1523/JNEUROSCI.23-18-07143.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liu C, Ye DW, Guan XH, Li RC, Xiang HB, Zhu WZ. Stimulation of the pedunculopontine tegmental nucleus may affect renal function by melanocortinergic signaling. Med Hypotheses. 2013;81:114–116. doi: 10.1016/j.mehy.2013.03.045. [DOI] [PubMed] [Google Scholar]
  • 13.Caruso V, Lagerstrom MC, Olszewski PK, Fredriksson R, Schioth HB. Synaptic changes induced by melanocortin signalling. Nat Rev Neurosci. 2014;15:98–110. doi: 10.1038/nrn3657. [DOI] [PubMed] [Google Scholar]
  • 14.Roseberry AG. Altered feeding and body weight following melanocortin administration to the ventral tegmental area in adult rats. Psychopharmacology (Berl) 2013;226:25–34. doi: 10.1007/s00213-012-2879-6. [DOI] [PubMed] [Google Scholar]
  • 15.Cui H, Mason BL, Lee C, Nishi A, Elmquist JK, Lutter M. Melanocortin 4 receptor signaling in dopamine 1 receptor neurons is required for procedural memory learning. Physiol Behav. 2012;106:201–210. doi: 10.1016/j.physbeh.2012.01.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Lippert RN, Ellacott KL, Cone RD. Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice. Endocrinology. 2014;155:1718–1727. doi: 10.1210/en.2013-2049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Oude Ophuis RJ, Boender AJ, van Rozen AJ, Adan RA. Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum. Front Neuroanat. 2014;8:14. doi: 10.3389/fnana.2014.00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Morales M, Root DH. Glutamate neurons within the midbrain dopamine regions. Neuroscience. 2014;282C:60–68. doi: 10.1016/j.neuroscience.2014.05.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ford CP, Mark GP, Williams JT. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci. 2006;26:2788–2797. doi: 10.1523/JNEUROSCI.4331-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Karachi C, Grabli D, Bernard FA, Tande D, Wattiez N, Belaid H, Bardinet E, Prigent A, Nothacker HP, Hunot S, Hartmann A, Lehericy S, Hirsch EC, Francois C. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest. 2010;120:2745–2754. doi: 10.1172/JCI42642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Bachmann LC, Matis A, Lindau NT, Felder P, Gullo M, Schwab ME. Deep brain stimulation of the midbrain locomotor region improves paretic hindlimb function after spinal cord injury in rats. Sci Transl Med. 2013;5:208ra146. doi: 10.1126/scitranslmed.3005972. [DOI] [PubMed] [Google Scholar]
  • 22.Ye DW, Liu C, Liu TT, Tian XB, Xiang HB. Motor cortex-periaqueductal gray-spinal cord neuronal circuitry may involve in modulation of nociception: a virally mediated transsynaptic tracing study in spinally transected transgenic mouse model. PLoS One. 2014;9:e89486. doi: 10.1371/journal.pone.0089486. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pan XC, Song YT, Liu C, Xiang HB, Lu CJ. Melanocortin-4 receptor expression in the rostral ventromedial medulla involved in modulation of nociception in transgenic mice. J Huazhong Univ Sci Technolog Med Sci. 2013;33:195–198. doi: 10.1007/s11596-013-1096-9. [DOI] [PubMed] [Google Scholar]
  • 24.Xiang HB, Liu C, Liu TT, Xiong J. Central circuits regulating the sympathetic outflow to lumbar muscles in spinally transected mice by retrograde transsynaptic transport. Int J Clin Exp Pathol. 2014;7:2987–2997. [PMC free article] [PubMed] [Google Scholar]
  • 25.Lindblom J, Opmane B, Mutulis F, Mutule I, Petrovska R, Klusa V, Bergstrom L, Wikberg JE. The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine. Neuroreport. 2001;12:2155–2158. doi: 10.1097/00001756-200107200-00022. [DOI] [PubMed] [Google Scholar]
  • 26.Barrett CE, Modi ME, Zhang BC, Walum H, Inoue K, Young LJ. Neonatal melanocortin receptor agonist treatment reduces play fighting and promotes adult attachment in prairie voles in a sex-dependent manner. Neuropharmacology. 2014;85C:357–366. doi: 10.1016/j.neuropharm.2014.05.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lute B, Jou W, Lateef DM, Goldgof M, Xiao C, Pinol RA, Kravitz AV, Miller NR, Huang YG, Girardet C, Butler AA, Gavrilova O, Reitman ML. Biphasic effect of melanocortin agonists on metabolic rate and body temperature. Cell Metab. 2014;20:333–45. doi: 10.1016/j.cmet.2014.05.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cui H, Lutter M. The expression of MC4Rs in D1R neurons regulates food intake and locomotor sensitization to cocaine. Genes Brain Behav. 2013;12:658–665. doi: 10.1111/gbb.12057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Richardson M. Deep brain stimulation for locomotor recovery following spinal cord injury. Neurosurgery. 2014;74:N18–19. doi: 10.1227/01.neu.0000442979.07078.ac. [DOI] [PubMed] [Google Scholar]
  • 30.Hong Q, Fang G, Liu TT, Guan XH, Xiang HB, Liu Z. Posterior pedunculopontine tegmental nucleus may be involved in visual complaints with intractable epilepsy. Epilepsy Behav. 2014;34C:55–57. doi: 10.1016/j.yebeh.2014.03.006. [DOI] [PubMed] [Google Scholar]
  • 31.Liu TT, Feng J, Bu HL, Liu C, Guan XH, Xiang HB. Stimulation for the compact parts of pedunculopontine nucleus: An available therapeutic approach in intractable epilepsy. Epilepsy Behav. 2013;29:252–3. doi: 10.1016/j.yebeh.2013.06.033. [DOI] [PubMed] [Google Scholar]
  • 32.Berglund ED, Liu T, Kong X, Sohn JW, Vong L, Deng Z, Lee CE, Lee S, Williams KW, Olson DP, Scherer PE, Lowell BB, Elmquist JK. Melanocortin 4 receptors in autonomic neurons regulate thermogenesis and glycemia. Nat Neurosci. 2014;17:911–913. doi: 10.1038/nn.3737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Mo XL, Tao YX. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors. Biochim Biophys Acta. 2013;1832:1939–1948. doi: 10.1016/j.bbadis.2013.06.006. [DOI] [PubMed] [Google Scholar]
  • 34.Pantel J, Williams SY, Mi D, Sebag J, Corbin JD, Weaver CD, Cone RD. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay. Eur J Pharmacol. 2011;660:139–147. doi: 10.1016/j.ejphar.2011.01.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Li P, Sun HJ, Zhang LL, Ding L, Han Y, Zhu GQ, Zhou YB. Melanocortin 4 receptors in the paraventricular nucleus modulate the adipose afferent reflex in rat. PLoS One. 2013;8:e80295. doi: 10.1371/journal.pone.0080295. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES